Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Regeneron (REGN) Stock Price & Analysis

REGN Stock Chart & Stats

$927.89$109.12(13.33%)
At close: 4:00 PM EDT
$750$800$850$9003 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$839.08 - $935.35
52-Week Range
$591.52 - $935.35
Previous Close
$818.77
Volume
174.31K
Average Volume (3M)
753.06K
Market Cap
$95.51B
Enterprise Value
$73.47B
Total Cash (Recent Filing)
$9.30B
Total Debt (Recent Filing)
$2.71B
Price to Earnings (P/E)
19.8
Beta
0.51
Next Earnings
Jan 29, 2027 (Est.)
EPS Estimate
24.25
Last Dividend Ex-Date
Aug 18, 2026
Dividend Yield
0.40%

Bulls Say, Bears Say

Bulls Say

Dupixent Growth

Dupixent combines rapid sales growth with broad adoption across nine inflammatory diseases and more than 1.5 million patients. This scale supports durable commercial momentum, strengthens Regeneron’s collaboration economics with Sanofi, and provides a substantial foundation for ongoing investment.

Expanded Sanofi Alliance

The expanded Sanofi relationship broadens Regeneron’s immunology pipeline while sharing development costs and global commercial risk. Regeneron retains lead development and U.S. regulatory roles, preserving strategic influence as new long-acting and bispecific therapies advance.

Balance Sheet And Cash Generation

Very low leverage and substantial recurring cash generation give Regeneron flexibility to fund research, business development, shareholder returns, and commercialization without relying heavily on external financing. This financial resilience supports execution through pipeline investment cycles.

Bears Say

EYLEA Franchise Pressure

EYLEA remains an important product franchise, but falling U.S. demand and increasing biosimilar competition create a durable headwind to revenue and pricing. EYLEA HD growth may partly offset erosion, yet ongoing substitution pressure could constrain portfolio-level expansion.

Margin Normalization

Regeneron remains highly profitable, but margins have normalized materially from earlier peaks. Lower profitability than prior years may limit operating leverage and reduce the earnings benefit from revenue growth, particularly as investment and commercial pressures increase.

Higher Investment And Tax Burden

A sharp increase in R&D spending reflects ambitious pipeline expansion but can pressure near-term operating margins before new products contribute revenue. A higher effective tax rate would further reduce earnings conversion, increasing execution demands across development programs.

Regeneron News

REGN FAQ

What was Regeneron’s price range in the past 12 months?
Regeneron lowest stock price was $591.52 and its highest was $935.35 in the past 12 months.
What is Regeneron’s market cap?
Regeneron’s market cap is $95.51B.
When is Regeneron’s upcoming earnings report date?
Regeneron’s next earnings report is estimated for Jan 29, 2027 (not yet confirmed), which is in 88 days.
How were Regeneron’s earnings last quarter?
Regeneron released its earnings results on Oct 30, 2026. The company reported $20.07 earnings per share for the quarter, beating the consensus estimate of $16.51 by $3.56.
Is Regeneron overvalued?
According to Wall Street analysts Regeneron’s price is currently Undervalued.
Does Regeneron pay dividends?
Regeneron pays a Quarterly dividend of $0.94 which represents an annual dividend yield of 0.4%. See more information on Regeneron dividends here
What is Regeneron’s EPS estimate?
Regeneron’s EPS estimate is 24.25.
How many shares outstanding does Regeneron have?
Regeneron has 101,137,840 shares outstanding.
What happened to Regeneron’s price movement after its last earnings report?
Regeneron reported an EPS of $20.07 in its last earnings report, beating expectations of $16.51. Following the earnings report the stock price went up 13.327%.
Which hedge fund is a major shareholder of Regeneron?
Hedge funds hold Regeneron shares: the largest hedge-fund position in Regeneron is 71,886,335 shares, and hedge funds increased their holdings by 637.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology